0000899243-21-014399.txt : 20210401
0000899243-21-014399.hdr.sgml : 20210401
20210401184329
ACCESSION NUMBER: 0000899243-21-014399
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210316
FILED AS OF DATE: 20210401
DATE AS OF CHANGE: 20210401
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Schor Chen
CENTRAL INDEX KEY: 0001340875
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38359
FILM NUMBER: 21799880
MAIL ADDRESS:
STREET 1: PREDIX PHARMACEUTICALS HOLDINGS, INC.
STREET 2: 4 MAGUIRE ROAD
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Adicet Bio, Inc.
CENTRAL INDEX KEY: 0001720580
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 813305277
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-482-2333
MAIL ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 12TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
FORMER COMPANY:
FORMER CONFORMED NAME: resTORbio, Inc.
DATE OF NAME CHANGE: 20171024
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2021-03-16
2021-03-18
0
0001720580
Adicet Bio, Inc.
ACET
0001340875
Schor Chen
C/O ADICET BIO, INC.
500 BOYLSTON STREET, 13TH FLOOR
BOSTON
MA
02116
1
1
0
0
President and CEO
Common Stock
2021-03-16
4
S
0
6474
15.07
D
155218
I
See footnote
Common Stock
2021-03-16
4
S
0
5395
15.66
D
129318
I
See footnote
Common Stock
2021-03-16
4
S
0
2508
15.07
D
152710
I
See footnote
Common Stock
2021-03-16
4
S
0
2089
15.66
D
127229
I
See footnote
Common Stock
2021-01-22
5
G
0
E
26070
D
0
D
Common Stock
2021-01-22
5
G
0
E
22985
D
0
I
See footnote
Common Stock
2021-01-22
5
G
0
E
23570
D
0
I
See footnote
Common Stock
2021-01-25
5
G
0
E
19286
D
0
I
See footnote
Common Stock
2021-01-25
5
G
0
E
27014
D
0
I
See footnote
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $14.49 to $15.48, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in prices ranging from $15.50 to $16.02, inclusive.
Represents 152,710 shares held directly by an irrevocable family trust having an independent trustee.
Represents 127,229 shares held directly by an irrevocable family trust having an independent trustee.
Represents 26,070 shares transferred by gift by the Reporting Person to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4.
Represents 22,985 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4.
Represents 23,570 shares transferred by gift by a revocable family trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4.
Represents 19,286 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person's spouse is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4.
Represents 27,014 shares transferred by gift by a grantor retained annuity trust of which the Reporting Person is the trustee to an irrevocable family trust having an independent trustee. The transaction is reportable on Form 5, but the Reporting Person is voluntarily reporting early on Form 4.
/s/ Nick Harvey, Attorney-in-Fact
2021-04-01